Thymosin Alpha-1 While Traveling: What Patients Need to Know

HealthRX.com

Plan sharps disposal and know its US approval status

Print or save as PDF

Key numbers

  • 1.6 mgItalian Zadaxin label dose, given subcutaneously or intramuscularly twice weeklySource: fda.gov, as cited Nov 8, 2026
  • 0.7 to 2 hoursTime for subcutaneous thymosin alpha-1 to peak in healthy volunteersSource: fda.gov, as cited Nov 8, 2026
  • 1.8 to 2.6 hoursHalf-life of subcutaneous thymosin alpha-1 in healthy volunteersSource: fda.gov, as cited Nov 8, 2026
  • US status / Not FDA-approved; the four orphan designations are a separate process, not an approval [1]
  • Labeled regimen (Italy) / Zadaxin 1.6 mg subcutaneously or intramuscularly twice weekly, 4 weeks from the first vaccination, then weeks 8 to 12 [1]
  • Half-life / About 1.8 to 2.6 hours; no accumulation after 5 daily doses [1]
  • Sport / Not named on WADA's 2026 Prohibited List; thymosin-beta-4 and TB-500 are named [3]
  • Sharps / FDA-cleared container, or a heavy-duty plastic container as an alternative; never loose in trash [4]
  • Compounding status / FDA's category 1 policy does not apply to it [5][6]

What you are actually carrying

Thymosin alpha-1 has no FDA approval: a Drugs@FDA search returns no US application, and the four orphan drug designations FDA noted in December 2024 are not approvals [1]. It is approved as a medicine in some other countries, including Italy, India and Hong Kong; in Italy, Zadaxin is authorized as an adjuvant to influenza vaccination in immunocompromised people [1]. Zadaxin is a finished injection sold outside the US (1.6 mg per vial) and is not interchangeable with bulk thymosin alpha-1 powder [1]. FDA's category 1 compounding policy does not apply to thymosin alpha-1. FDA's page on bulk substances with significant safety risks lists it in the "nominated but withdrawn" table, and FDA's posted concerns about immunogenicity for certain routes of administration remain [5][6][7].

Label schedule and half-life

Italy's Zadaxin label gives 1.6 mg subcutaneously or intramuscularly twice weekly for 4 weeks starting at the first vaccination, repeated from week 8 to week 12 [1]. No US-approved dose exists [1]. In healthy volunteers, subcutaneous thymosin alpha-1 peaked at about 0.7 to 2 hours and cleared with a half-life of about 1.8 to 2.6 hours, with no accumulation after five daily doses [1][2].

Label cautions

The Italian Zadaxin label says the product is not for children and is contraindicated in pregnancy and breastfeeding. It calls for caution in people with allergies or autoimmune disease and with other immune-modulating drugs [1]. FDA's April 22, 2024 search of its adverse-event database found zero reports for thymosin alpha-1 [1].

Is it a banned substance in sport?

Thymosin alpha-1 is not named on WADA's 2026 Prohibited List. That list names thymosin-beta-4 and its derivatives such as TB-500 under S2.3, which are different peptides [3]. S0 covers substances with no approval from any governmental health authority, and thymosin alpha-1 is approved in some countries [3][1].

Syringes and sharps

FDA's sharps guidance covers travel. Used sharps go straight into an FDA-cleared container with puncture-resistant plastic, leak-resistant sides and bottom and a tight-fitting lid, or a heavy-duty plastic household container such as a laundry detergent bottle as an alternative [4]. FDA says never to place loose sharps in household or public trash or recycling bins, and never to flush them [4].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the article, what is the FDA approval status of thymosin alpha-1 in the US?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Questions worth asking

Choose the questions you want to keep

Is thymosin alpha-1 FDA-approved?
No. There is no US application for it, and the four orphan drug designations FDA noted in December 2024 are not approvals [1]. It is approved as a medicine in some other countries, including Italy, India and Hong Kong [1].
What schedule does the label give?
Italy's Zadaxin label gives 1.6 mg subcutaneously or intramuscularly twice weekly for 4 weeks starting at the first vaccination, repeated from week 8 to week 12 [1]. No US-approved dose exists [1].
Is thymosin alpha-1 on the WADA banned list?
It is not named on WADA's 2026 Prohibited List. Thymosin-beta-4 and TB-500 are named under growth factors, and they are different peptides [3].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

When is the best time to take thymosin alpha 1 peptide?

No best time of day is established. The Italian Zadaxin label gives 1.6 mg subcutaneously or intramuscularly twice weekly for 4 weeks starting at the first vaccination, repeated from week 8 to week 12. No US-approved dose exists.

How long does it take to see results from thymosin alpha 1?

How long results take is not established. The labeled timing is twice-weekly doses for 4 weeks from the first vaccination, repeated from week 8 to week 12. In healthy volunteers, the half-life was about 1.8 to 2.6 hours, with no accumulation after five daily doses.

Show all 7 referencesHide references
Evidence overview for Thymosin Alpha-1 While Traveling: What Patients Need to Know